Compugen Announces FDA Clearance of IND Application for COM902 false

קומפיוגן בע"מ	2 380
COMPUGEN LTD
Corporation no: 511779639	10473

	Israel Securities Authority			Tel Aviv Stock Exchange		C002 ( Public )		Reported via MAGNA:	04/11/2019
	www.isa.gov.il			www.tase.co.il				Reference:	2019-02-107743	Time of broadcast: 13:45 13:44:24

Immediate Report

Regulation 4 of the Securities Regulations, (Periodic and Immediate Reports of Foreign Corporation) 5761-2000

The corporation is a foreign private issuer as defined by U.S. Securities Laws.

Attached hereto is a report on

Compugen Announces FDA Clearance of IND Application for COM902

6k_isa.pdf

References of previous documents relating to this matter(the reference does not constitute incorporation by reference):
Stock Exchange/Market: TASE	Date of revision of form structure: 29/10/2019
Address: Harokmim 26 , Holon 5885849   , Israel Tel: 03-7658585 , 03-7658525 Fax: 03-7658555
E-mail address: donnag@cgen.com
Previous names of reporting entity:
Name of the Signatory: Krashin Ari Position of Signatory in the reporting corporation: Chief Financial Officer Name of Employer Company:
Address: Pinchas Rosen 72 , Tel Aviv 6951294 Telephone: 054-2244899 Facsimile: 03-7658555 E-mail: arik@cgen.com 1
Israel